• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Agriculture

Discovering Coffee’s Secret Chemistry: Novel Diterpenes Reveal Potential Anti-Diabetic Benefits

Bioengineer by Bioengineer
September 6, 2025
in Agriculture
Reading Time: 3 mins read
0
Discovering Coffee’s Secret Chemistry: Novel Diterpenes Reveal Potential Anti-Diabetic Benefits
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A recent groundbreaking study from the Kunming Institute of Botany, Chinese Academy of Sciences, has unveiled a novel methodology to identify biologically active diterpene esters in roasted Coffea arabica beans, spotlighting their promising potential in diabetes management. This cutting-edge research, published on February 18, 2025, in the prestigious open-access journal Beverage Plant Research, integrates advanced nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-tandem mass spectrometry (LC-MS/MS) molecular networking to accelerate the discovery of functional food components with potent α-glucosidase inhibitory activity.

Type 2 diabetes, a global health challenge characterized by impaired glucose metabolism, demands innovative strategies to regulate postprandial blood sugar levels. α-Glucosidase, a critical enzyme in carbohydrate digestion, represents a validated therapeutic target for managing hyperglycemia. The newly isolated diterpene esters from coffee, showing superior inhibitory efficacy compared to acarbose—the current standard α-glucosidase inhibitor—open a promising avenue for developing coffee-derived nutraceuticals.

The research team implemented a meticulous three-step bioactivity-guided fractionation approach to isolate and characterize these compounds from complex coffee matrices. Initially, crude diterpene extracts underwent silica gel chromatography fractionation, yielding nineteen discrete fractions subjected to both ^1H NMR spectral analysis and enzymatic activity screening. This integrative approach allowed rapid identification of bioactive fractions, specifically fractions 9 through 13, marked by distinctive proton resonances correlating with α-glucosidase inhibition.

.adsslot_TnfZXhwoab{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_TnfZXhwoab{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_TnfZXhwoab{width:320px !important;height:50px !important;}
}

ADVERTISEMENT

Further structural elucidation of the most potent fraction (Fr.9) employed ^13C-DEPT NMR, unveiling the presence of an aldehyde functional group, a characteristic confirmed by complementary ^1H NMR data. Subsequent semi-preparative high-performance liquid chromatography (HPLC) purification isolated three novel diterpene esters, termed caffaldehydes A, B, and C. Their molecular structures were definitively elucidated using sophisticated 1D and 2D NMR techniques alongside high-resolution electrospray ionization mass spectrometry (HRESIMS), revealing differing fatty acid conjugations—palmitic, stearic, and arachidic acids respectively.

Quantitative bioactivity assays demonstrated that these isolated diterpenes exhibit moderate to strong α-glucosidase inhibitory effects, with half-maximal inhibitory concentrations (IC₅₀) of 45.07 μM, 24.40 μM, and 17.50 μM, respectively. Notably, these values surpass those of acarbose, underscoring the therapeutic relevance of these naturally derived compounds. This finding substantiates the hypothesis that specific diterpenes present in roasted coffee contribute significantly to its glucose-lowering properties.

To transcend the limitations of NMR and HPLC sensitivity in detecting trace bioactives, the investigators employed LC-MS/MS combined with Global Natural Products Social (GNPS) molecular networking and Cytoscape visualization. This advanced dereplication strategy facilitated the recognition of related unknown diterpene esters—compounds 4 through 6—featuring fatty acid moieties such as magaric, octadecenoic, and nonadecanoic acids. The absence of these entities in existing chemical databases underscores their novelty and expands the chemical diversity of bioactive coffee metabolites.

This integrative dereplication pipeline, characterized by its minimal solvent requirements and expedited spectral analysis, presents a scalable framework applicable to diverse and chemically complex food matrices beyond coffee. It significantly streamlines the discovery process for functional food ingredients harboring pharmacologically relevant bioactivities, thus promising to revolutionize the pace at which new nutraceutical candidates are identified and developed.

Moreover, the study underscores the need to further elucidate the mechanistic underpinnings of how these diterpenoids interact with α-glucosidase at the molecular level, potentially guiding the rational design of more potent derivatives. Given the complexity of diabetes pathophysiology, multifunctional compounds with complementary antioxidant or neuroprotective activities—as often found in coffee—may yield synergistic health benefits.

The authors acknowledge that while in vitro assays demonstrate promising enzyme inhibition, translational research encompassing pharmacokinetics, bioavailability, and targeted delivery remains essential to confirm clinical utility. In vivo studies to assess metabolic stability, toxicity profiles, and efficacy in animal models are planned, paving the way toward human trials and eventual commercialization.

This pioneering work emerges at the intersection of analytical chemistry, metabolomics, and functional food research, showcasing how contemporary instrumental techniques explain and exploit the health virtues of traditionally consumed beverages. It also exemplifies the immense potential embedded in natural food matrices waiting to be unlocked through innovative science.

In conclusion, the identification of these novel diterpene esters constitutes a leap forward in functional food research, highlighting roasted Coffea arabica beans as a reservoir of bioactive molecules with potential clinical relevance for diabetes care. The integrative, solvent-efficient strategy delineated herein holds promise not only for coffee but also other complex food systems, potentially catalyzing a paradigm shift in natural product discovery for health promotion.

Subject of Research: Not applicable

Article Title: Bioactive oriented discovery of diterpenoids in Coffea arabica basing on 1D NMR and LC-MS/MS molecular network

News Publication Date: 18-Feb-2025

References: 10.48130/bpr-0024-0035

Keywords: Plant sciences, Agriculture, Technology

Tags: anti-diabetic compoundsbioactivity-guided fractionationcoffee chemistrycoffee-derived health benefitsditerpenes in coffeefunctional food componentsliquid chromatography-tandem mass spectrometryNMR spectroscopy in food researchnutraceutical developmentpostprandial blood sugar controltype 2 diabetes managementα-glucosidase inhibitors

Share14Tweet9Share2ShareShareShare2

Related Posts

Study Reveals Modulated UV-C Light Extends Guava Shelf Life

Study Reveals Modulated UV-C Light Extends Guava Shelf Life

February 6, 2026
Binghamton University Scientist to Lead $2.5 Million Initiative for Enhanced Avian Flu Vaccine Development

Binghamton University Scientist to Lead $2.5 Million Initiative for Enhanced Avian Flu Vaccine Development

February 6, 2026

First ASU–Science Prize Honors Groundbreaking Research Empowering Farmers

February 6, 2026

Rising Pesticide Toxicity Jeopardizes UN’s 2030 Global Biodiversity Protection Targets

February 5, 2026

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

Barriers and Boosters of Seniors’ Physical Activity in Karachi

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.